These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36413539)

  • 1. Artificial pancreas systems: experiences from concept to commercialisation.
    Rodríguez-Sarmiento DL; León-Vargas F; García-Jaramillo M
    Expert Rev Med Devices; 2022 Nov; 19(11):877-894. PubMed ID: 36413539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Efficacy of Basal Rate and Carbohydrate Ratio Learning Algorithm for Closed-Loop Insulin Delivery (Artificial Pancreas) in Youth with Type 1 Diabetes in a Diabetes Camp.
    Palisaitis E; El Fathi A; Von Oettingen JE; Krishnamoorthy P; Kearney R; Jacobs P; Rutkowski J; Legault L; Haidar A
    Diabetes Technol Ther; 2020 Mar; 22(3):185-194. PubMed ID: 31596127
    [No Abstract]   [Full Text] [Related]  

  • 3. Automated Insulin Delivery in Real Life (AID-IRL): Real-World User Perspectives on Commercial AID.
    Lewis D
    J Diabetes Sci Technol; 2022 Mar; 16(2):500-503. PubMed ID: 32935554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How It Started, How It Is Going: The Future of Artificial Pancreas Systems (Automated Insulin Delivery Systems).
    Lewis D
    J Diabetes Sci Technol; 2021 Nov; 15(6):1258-1261. PubMed ID: 34218717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [What is the current state of the artificial pancreas in diabetes care?].
    Dimou M; Laimer M; Stettler C; Bally L
    Internist (Berl); 2020 Jan; 61(1):102-109. PubMed ID: 31863132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Future of Automated Insulin Delivery (AID) Systems.
    Garg SK; McVean JJ
    Diabetes Technol Ther; 2024 Mar; 26(S3):1-6. PubMed ID: 38377322
    [No Abstract]   [Full Text] [Related]  

  • 7. Closed-Loop Artificial Pancreas Therapy for Type 1 Diabetes.
    Zhou K; Isaacs D
    Curr Cardiol Rep; 2022 Sep; 24(9):1159-1167. PubMed ID: 35727409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current topics in glycemic control by wearable artificial pancreas or bedside artificial pancreas with closed-loop system.
    Hanazaki K; Munekage M; Kitagawa H; Yatabe T; Munekage E; Shiga M; Maeda H; Namikawa T
    J Artif Organs; 2016 Sep; 19(3):209-18. PubMed ID: 27142278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated blood glucose control in type 1 diabetes: A review of progress and challenges.
    Bertachi A; Ramkissoon CM; Bondia J; Vehí J
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Mar; 65(3):172-181. PubMed ID: 29279252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated insulin delivery systems: from early research to routine care of type 1 diabetes.
    Renard E
    Acta Diabetol; 2023 Feb; 60(2):151-161. PubMed ID: 35994106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Status and Emerging Options for Automated Insulin Delivery Systems.
    Forlenza GP; Lal RA
    Diabetes Technol Ther; 2022 May; 24(5):362-371. PubMed ID: 35099302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Who needs an artificial pancreas? (？).
    Winikoff J; Drexler A
    J Diabetes; 2013 Sep; 5(3):254-7. PubMed ID: 23601378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing automatic closed-loop glucose control in type 1 diabetes with an adaptive meal bolus calculator - in silico evaluation under intra-day variability.
    Herrero P; Bondia J; Adewuyi O; Pesl P; El-Sharkawy M; Reddy M; Toumazou C; Oliver N; Georgiou P
    Comput Methods Programs Biomed; 2017 Jul; 146():125-131. PubMed ID: 28688482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
    Clarke WL; Anderson S; Breton M; Patek S; Kashmer L; Kovatchev B
    J Diabetes Sci Technol; 2009 Sep; 3(5):1031-8. PubMed ID: 20144416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do-It-Yourself and Commercial Automated Insulin Delivery Systems in Type 1 Diabetes: An Uncertain Area for Canadian Health-care Providers.
    Morrison AE; Senior PA; Bubela T; Farnsworth K; Witteman HO; Lam A
    Can J Diabetes; 2022 Dec; 46(8):863-870. PubMed ID: 35945126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Closed-loop systems - Update 2020].
    Melmer A; Tripyla A; Herzig D; Laimer M; Stettler C; Bally L
    Ther Umsch; 2020 Sep; 77(7):312-318. PubMed ID: 32996429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative Considerations for Evolving Artificial Pancreas Devices.
    Long MT; Coursin DB; Rice MJ
    Anesth Analg; 2019 May; 128(5):902-906. PubMed ID: 30198923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do-It-Yourself Artificial Pancreas Systems: A Review of the Emerging Evidence and Insights for Healthcare Professionals.
    Jennings P; Hussain S
    J Diabetes Sci Technol; 2020 Sep; 14(5):868-877. PubMed ID: 31847570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.
    Bruttomesso D; Farret A; Costa S; Marescotti MC; Vettore M; Avogaro A; Tiengo A; Dalla Man C; Place J; Facchinetti A; Guerra S; Magni L; De Nicolao G; Cobelli C; Renard E; Maran A
    J Diabetes Sci Technol; 2009 Sep; 3(5):1014-21. PubMed ID: 20144414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial Pancreas Technology Offers Hope for Childhood Diabetes.
    Schoelwer MJ; DeBoer MD
    Curr Nutr Rep; 2021 Mar; 10(1):47-57. PubMed ID: 33411096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.